Evidence map›Paper›PMID 30156626›Full record

ArticleAnais brasileiros de dermatologia

Disseminated fusariosis with cutaneous involvement in hematologic malignancies: report of six cases with high mortality rate.

Marina Zoéga Hayashida, Camila Arai Seque, Milvia Maria Simões E Silva Enokihara, Adriana Maria Porro

Abstract readCase Reports
In one paragraph

Article in Anais brasileiros de dermatologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. First Demonstration of ClinicalMicroorganisms · 2020
    Article
  8. The skin and soft tissue infections in hematological patients.Current opinion in infectious diseases · 2020
    Review
  9. Human fusariosis: An emerging infection that is difficult to treat.Revista da Sociedade Brasileira de Medicina Tropical · 2020
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marina Zoéga HayashidaDepartment of Dermatology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo (SP), Brazil.ORCID 0000-0002-2960-3134
Camila Arai SequeDepartment of Dermatology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo (SP), Brazil.ORCID 0000-0001-8145-268X
Milvia Maria Simões E Silva EnokiharaDepartment of Pathology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo (SP), Brazil.ORCID 0000-0002-3340-4074
Adriana Maria PorroDepartment of Dermatology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo (SP), Brazil.ORCID 0000-0003-0736-4790

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fusariosis is due to inhalation or direct contact with conidia. Clinical presentation depends on host's immunity and can be localized, focally invasive or disseminated. Given the severity of this infection and the possibility for the dermatologist to make an early diagnosis, we report six cases of patients with hematologic malignancies, who developed febrile neutropenia an skin lesions suggestive of cutaneous fusariosis. All patients had skin cultures showing growth of Fusarium solani complex, and they received amphotericin B and voriconazole. As this infection can quickly lead to death, dermatologists play a crucial role in diagnosing this disease.

Indexed as

AdultAntifungal AgentsFatal OutcomeFusariosisFusariumHumansLeukemia, Myeloid, AcuteMiddle AgedMultiple MyelomaNeutropeniaPrecursor Cell Lymphoblastic Leukemia-LymphomaSkinYoung AdultAntifungal Agents

Identifiers

PMID30156626
PMCPMC6106674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.